PK Study to Assess Drug-drug Interaction Between Sitravatinib and a P-gp Inducer and an Inhibitor.

NCT05255276 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adults

Interventions

DRUG: Sitravatinib 50 mg
DRUG: Sitravatinib 100 mg
DRUG: Itraconazole
DRUG: Rifampin

Sponsor

Mirati Therapeutics Inc.